Aliskiren hemifumarate
-
Aliskiren hemifumarate
structure -
-
CAS No:
173334-58-2
-
Formula:
C30H53N3O6.1/2C4H4O4
-
Chemical Name:
Aliskiren hemifumarate
-
Synonyms:
Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,(αS,γS,δS,ζS)-,(2E)-2-butenedioate (2:1);Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,[αS-(αR*,γR*,δR*,ζR*)]-,(E)-2-butenedioate (2:1) (salt);Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,(αS,γS,δS,ζS)-,(2E)-2-butenedioate (2:1) (salt);Aliskiren hemifumarate;Aliskiren fumarate
- Categories:
-
CAS No:
Description
Aliskiren hemifumarate(CGP 60536) is a direct renin inhibitor with IC50 of 1.5 nM.IC50 value: 1.5 nM [1]Target: reninin vitro: Aliskiren hemifumarate appears to bind to both the hydrophobic S1/S3-binding pocket and to a large, distinct subpocket that extends from the S3-binding site towards the hydrophobic core of renin. Oral bioavailability of Aliskiren hemifumarate is 2.4% in rats, 16% in marmosets and about 2.5% in humans [2].in vivo: Aliskiren hemifumarate (< 10 mg/kg, oral) inhibits
Characteristics
366.86000
9.88180
108-115 °C
Hygroscopic, -20°C Freezer, Under Inert Atmosphere
1.59E-23mmHg at 25°C
Safety Information
|Danger|H302 (16.67%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P264, P270, P271, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P314, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 12 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Aliskiren hemifumarate Use and Manufacturing
An orally active, synthetic nonpeptide renin inhibitor. Antihypertensive.
Computed Properties
Molecular Weight:667.8
Hydrogen Bond Donor Count:6
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:21
Exact Mass:667.40439502
Monoisotopic Mass:667.40439502
Topological Polar Surface Area:221
Heavy Atom Count:47
Complexity:836
Defined Atom Stereocenter Count:4
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Aliskiren hemifumarate
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on Aliskiren hemifumarate
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Aliskiren inter-10
365541-74-8
-
Aliskiren inter-9
866030-33-3
-
Aliskiren InterMediates
393108-57-1
-
Aliskiren inter-8 Formula
172900-83-3
-
Aliskiren inter-7 Formula
387353-71-1
-
Aliskiren Formula
173334-57-1
-
1-(4-Benziloxy-3-formylaminophenyl)-2-[N-benzyl-2'-(4-methoxyphenyl)-1'-methylethylamino]ethaol hemifumarate Structure
143687-24-5
-
Aliskiren inter-11 Structure
387353-77-7
-
What is Dabrafenib
1195765-45-7
-
What is BOC-VAL-VAL-OH
69209-73-0